Paper: Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series
Paper: PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis
Paper: Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines
Paper: Specialized Cell-Free DNA Blood Collection Tubes Can Be Repurposed for Extracellular Vesicle Isolation: A Pilot Study
Paper: Unmet needs in the global NETs patient community: an assessment of major gaps from the perspectives of patients, patient advocates and NET health professionals
Paper: Pancreatic Grade 3 Neuroendocrine Tumors Behave Similarly to Neuroendocrine Carcinomas Following Resection: A Multi-Center, International Appraisal of the WHO 2010 and WHO 2017 Staging Schema for Pancreatic Neuroendocrine Lesions
Paper: Patient characteristics and clinical outcomes following initial surgical intervention for MEN1 associated pancreatic neuroendocrine tumors: a systematic review and exploratory meta-analysis of the literature.
Paper: Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localised pancreatic cancer.
Poster: A Spatial Proteomics Approach Identifies Novel Immuno- Oncology Markers for Merkel Cell Carcinoma, European Neuroendocrine Tumor Society (ENETS) 2019
Poster: The NETwork! Registry analysis supports the WHO 2017 classification in the first NET specific survival analysis for a complete population, European Neuroendocrine Tumor Society (ENETS) 2019
Poster: Understanding Tumour Evolution of a Highly Disseminated Lung NET through Multi-player Augmented Reality Visualisation, European Neuroendocrine Tumor Society (ENETS) 2019
Poster: Investigating Tumour Evolution in a Single Patient with Disseminated Cancer, Queenstown Research Week (Cancer Satellite) 2018
Poster: New Zealand Merkel Cell Carcinomas present with body laterality probably not linked to sun exposure, NZSO 2018
Paper: Genomic medicine must reduce, not compound, health inequities: the case for hauora-enhancing genomic resources for New Zealand
Paper: A pilot study of exome sequencing in a diverse New Zealand cohort with undiagnosed disorders and cancer.
Special Communication: Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors
Journal Article: Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer
Poster: A Novel Classification of Pancreatic Neuroendocrine Tumors (pNETs) Guided by Genomics, ENETS Conference 2018
Poster: The NETwork! Registry Suggests Increasing Incidence in a National Study of Neuroendocrine Cancer in New Zealand (NZ), ENETS Conference 2018
Poster: Approaching NETs from Many Angles: A Medical Research Paradigm to Challenge New Zealand’s Research Traditions, ENETS Conference 2018
Poster: Enhancing Diagnostic Precision Through Combined Genomic and Histopathological Analysis of Pancreatic Neuroendocrine Tumors, ENETS Conference 2018
Poster: Homing in on precise diagnoses: The power of combining multi-layered genomic and histopathological analysis in pancreatic neuroendocrine cancer, AGTA 2017
Poster: Technical advances in plasma genomic biomarkers for mutational detection and monitoring in cancer patients, AGTA 2017
Journal article pre-print: Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer; pre-print on BioRxIV November 2017
Poster: The NETwork! Registry: Preliminary data suggests increasing incidence in a national study of neuroendocrine cancer in New Zealand (NZ), NZSO 2017
Poster: Development of Merkel Polyoma Virus detection assays for accurate diagnosis of Merkel Cell Carcinoma, NZSO 2017
Poster: The NETwork! Registry: Preliminary data suggests increasing incidence in a national study of neuroendocrine cancer in New Zealand; AGIGT 2017
Poster Presentation: Three distinct genomic landscapes define clinical outcome of pancreatic neuroendocrine tumours (pNETs); AGIGT 2017
Paper: Current challenges in optimizing systemic therapy for patients with pancreatic cancer: Expert perspectives from the Australian Gastrointestinal Trials Group with invited international faculty.
Abstract: Pancreatic neuroendocrine tumour (pNET) profiles in the NETwork! programme: clinic–enabled genomics for genomic-enabled clinical decisions Ann Onc 2016
Paper: Minichromosome Maintenance Expression Defines Slow-Growing Gastroenteropancreatic Neuroendocrine Neoplasms.
Paper: Identifying and prioritising gaps in neuroendocrine tumor research: a modified Delphi process with patients and health care providers to set the research action plan for the newly formed Commonwealth Neuroendocrine Tumour Collaboration (CommNETs).
Poster: PUKUmahi!: Kia whai te huarahi tika. NETwork! Roadmap for safe travel: Ensuring health benefits flow on to Māori, NZSO 2015
Paper: Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling.
Paper: GNA15 Expression in Small Intestinal Neuroendocrine Neoplasia: Functional and Signalling Pathways Analyses.
Poster: The New Zealand Cancer Registry is not a complete record of neuroendocrine malignancy. NZSO 2014
Poster: Systemic treatment outcomes for neuroendocrine tumour (NET) patients in the Auckland Region: Preliminary analysis of the NETwork Registry, NZSO 2014
Paper: Culture, law, ethics, and social implications: Is society ready for advanced genomic medicine?
Paper: A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases.